Literature DB >> 14364747

A new orally active quaternary ammonium, ganglion blocking drug capable of reducing blood pressure, Su-3088.

K S GRIMSON, A K TARAZI, J W FRAZER.   

Abstract

Entities:  

Keywords:  AUTONOMIC DRUGS/therapeutic use; HYPERTENSION/therapy

Mesh：

Substances：

Year:  1955        PMID： 14364747     DOI： 10.1161/01.cir.11.5.733

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  10 in total

1.  Current drug therapy of essential hypertension in relation to some of the non-renal factors which participate in the maintenance of blood pressure.

Authors:  S LOCKET
Journal:  Postgrad Med J       Date:  1957-03       Impact factor: 2.401

2.  [Clinical studies on the deblocking properties of prostigmine in ganglion blockade induced by ecolid and pendiomide].

Authors:  J GOERRE
Journal:  Klin Wochenschr       Date:  1957-11-15

3.  Ecolid: a new hypotensive agent.

Authors:  R D MAXWELL; T J G HOWIE
Journal:  Br Med J       Date:  1955-11-12

4.  Drug treatment of hypertension.

Authors:  E G MCQUEEN; F H SMIRK
Journal:  Postgrad Med J       Date:  1956-02       Impact factor: 2.401

5.  [The importance of experimental analysis for the therapeutic use of hypotensive drugs].

Authors:  F GROSS
Journal:  Klin Wochenschr       Date:  1955-12-15

6.  Effects of nicotine and chlorisondamine on cerebral glucose utilization in immobilized and freely-moving rats.

Authors:  T Marenco; S Bernstein; P Cumming; P B Clarke
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

7.  Intraneuronal accumulation and persistence of radiolabel in rat brain following in vivo administration of [3H]-chlorisondamine.

Authors:  H el-Bizri; M G Rigdon; P B Clarke
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

8.  The pharmacology of the nicotinic antagonist, chlorisondamine, investigated in rat brain and autonomic ganglion.

Authors:  P B Clarke; I Chaudieu; H el-Bizri; P Boksa; M Quik; B A Esplin; R Capek
Journal:  Br J Pharmacol       Date:  1994-02       Impact factor: 8.739

9.  Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine and other nicotinic antagonists administered in vitro.

Authors:  H el-Bizri; P B Clarke
Journal:  Br J Pharmacol       Date:  1994-02       Impact factor: 8.739

10.  Use of chlorisondamine to assess the neurogenic contribution to blood pressure in mice: An evaluation of method.

Authors:  Lucas Ac Souza; Silvana G Cooper; Caleb J Worker; Pratish Thakore; Yumei Feng Earley
Journal:  Physiol Rep       Date:  2021-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.